Mark Burton
Impact in
- Cancer Research top 5%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Neurology top 10%
- Neuroinflammation and Neurodegeneration Mechanisms
Papers in
-
- RNA Research and Splicing 3
- Circular RNAs in diseases 3
-
- Breast Cancer Treatment Studies 4
- Cancer-related molecular mechanisms research 4
- Cancer Genomics and Diagnostics 3
- Co-authors
- Mads Thomassen (40 shared papers)Torben A. Kruse (24 shared papers)Nils J. Færgeman (2 shared papers)Jens Knudsen (2 shared papers)Qihua Tan (11 shared papers)Martin J. Larsen (7 shared papers)Søren Cold (5 shared papers)Martin Bak (5 shared papers)
- Journals
- Neuro-Oncology (5 papers)PLoS ONE (3 papers)Breast Cancer Research (3 papers)The Journal of Rheumatology (2 papers)Surgical Oncology (2 papers)
- Partner nations
- DenmarkUnited StatesGermany
In The Last Decade
Mark Burton
57 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 101
- Cancer Research 405
- Neurology 83
- Biochemistry 74
- Molecular Biology 625
- Genetics 90
Countries citing papers authored by Mark Burton
This map shows the geographic impact of Mark Burton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Burton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Burton more than expected).
Fields of papers citing papers by Mark Burton
This network shows the impact of papers produced by Mark Burton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Burton. The network helps show where Mark Burton may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark Burton, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 64 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 228 | |
| 2 | 2005 | 130 | |
| 3 | 2006 | 72 | |
| 4 | 2019 | 64 | |
| 5 | 2021 | 55 | |
| 6 | 2015 | 51 | |
| 7 | 2018 | 49 | |
| 8 | 2017 | 41 | |
| 9 | 2014 | 39 | |
| 10 | 2021 | 32 | |
| 11 | 2016 | 29 | |
| 12 | 1982 | 25 | |
| 13 | 2016 | 25 | |
| 14 | 2023 | 25 | |
| 15 | 2018 | 25 | |
| 16 | 2000 | 23 | |
| 17 | 2016 | 19 | |
| 18 | 2020 | 18 | |
| 19 | 2020 | 17 | |
| 20 | 2012 | 14 |
About Mark Burton
Mark Burton is a scholar working on Molecular Biology, Cancer Research, Genetics, Pathology and Forensic Medicine and Oncology, having authored 64 papers that have together received 1.2k indexed citations. Recurring topics across this work include Multiple Sclerosis Research Studies (6 papers), Glioma Diagnosis and Treatment (6 papers), Breast Cancer Treatment Studies (4 papers), Cancer-related molecular mechanisms research (4 papers), Cancer Cells and Metastasis (3 papers), RNA Research and Splicing (3 papers), Cancer Genomics and Diagnostics (3 papers) and Circular RNAs in diseases (3 papers). The work is most often cited by research in Cancer Research (405 citations), Neurology (83 citations), Biochemistry (74 citations), Molecular Biology (625 citations) and Genetics (90 citations). Mark Burton has collaborated with scholars based in Denmark, United States and Germany. Frequent co-authors include Mads Thomassen, Torben A. Kruse, Nils J. Færgeman, Jens Knudsen, Qihua Tan, Martin J. Larsen, Søren Cold, Martin Bak, Kristina P. Sørensen and Timothy M. Rose. Their work appears in journals such as Neuro-Oncology, PLoS ONE, Breast Cancer Research, The Journal of Rheumatology and Surgical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.